Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) closed at $16.91 in the last session, down -0.94% from day before closing price of $17.07. In other words, the price has decreased by -$0.94 from its previous closing price. On the day, 0.52 million shares were traded. ARCT stock price reached its highest trading level at $17.5 during the session, while it also had its lowest trading level at $16.2.
Ratios:
We take a closer look at ARCT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.76 and its Current Ratio is at 4.76. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on August 12, 2024, initiated with a Outperform rating and assigned the stock a target price of $70.
On December 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $90.
On July 24, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $71.William Blair initiated its Outperform rating on July 24, 2023, with a $71 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 15 ’24 when Chivukula Pad sold 12,000 shares for $20.76 per share. The transaction valued at 249,121 led to the insider holds 435,334 shares of the business.
Chivukula Pad bought 12,000 shares of ARCT for $249,121 on Oct 15 ’24. On Jun 12 ’24, another insider, SASSINE ANDY, who serves as the Chief Financial Officer of the company, sold 50,000 shares for $32.03 each. As a result, the insider received 1,601,500 and left with 220,526 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARCT now has a Market Capitalization of 458047936 and an Enterprise Value of 250291248. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.12 while its Price-to-Book (P/B) ratio in mrq is 1.75. Its current Enterprise Value per Revenue stands at 1.56 whereas that against EBITDA is -3.25.
Stock Price History:
Over the past 52 weeks, ARCT has reached a high of $45.00, while it has fallen to a 52-week low of $14.93. The 50-Day Moving Average of the stock is -16.39%, while the 200-Day Moving Average is calculated to be -36.35%.
Shares Statistics:
According to the various share statistics, ARCT traded on average about 383.87K shares per day over the past 3-months and 607020 shares per day over the past 10 days. A total of 26.83M shares are outstanding, with a floating share count of 24.58M. Insiders hold about 9.27% of the company’s shares, while institutions hold 88.43% stake in the company. Shares short for ARCT as of 1730332800 were 4580249 with a Short Ratio of 11.93, compared to 1727654400 on 4596273. Therefore, it implies a Short% of Shares Outstanding of 4580249 and a Short% of Float of 26.51.
